Top Markets
#1 GEKKO GEKKO +51.79%
#2 Helium Helium +45.36%
#3 ADO Protocol ADO Protocol +38.91%
#4 Prom Prom +34.97%
#5 Pons Pons +33.94%
#6 TENDIES TENDIES +31.01%
#7 Collector Crypt Collector Crypt +28.01%
#8 StonkBroker StonkBroker +26.08%
#9 Collect on Fanable Collect on Fanable +20.42%
#10 Cysic Cysic +20.13%
Coin of the day
GEKKO GEKKO
設定
言語
日本
通貨
USD
テーマ
Orum Therapeutics, Inc. Orum Therapeutics, Inc.

Orum Therapeutics, Inc.

475830
株式のランク #9664
Orum Therapeutics, Inc. is a biopharmaceutical company dedicated to the... Orum Therapeutics, Inc. is a biopharmaceutical company dedicated to the discovery and development of novel therapeutic solutions for both cancer and immune system conditions. The firm specializes in creating degrader-antibody conjugates, an innovative class of drugs that merges traditional antibody-drug conjugate (ADC) technology with targeted protein degradation. Their flagship product candidate, ORM-1153, functions as a GSPT1 protein degrader, specifically engineered to address hematologic malignancies. Orum Therapeutics was established in 2016 and operates out of Daejeon, South Korea.
株価
$45.64
最終同期: 2026-08-28
時価総額
$969.02M
変化（1日）
-1.20%
変化（1年）
146.66%
国
KR
取引 Orum Therapeutics, Inc. (475830)

カテゴリー

Healthcare
Orum Therapeutics, Inc.（475830）のP/S比率
2026 時点のP/S比率 TTM: 0
Orum Therapeutics, Inc. の最新の財務報告および株価によると、現在のP/S比率（TTM）は 0 です。2026 年末時点でのP/S比率は 0 でした。
Orum Therapeutics, Inc. の P/S 比率の履歴（2026 ～ 2026）
各年末時点のP/S比率
年 P/S比率 変化
提供された日付のデータは十分ではありません。
同業他社のP/S比率
企業 P/S比率 P/S比率の差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH